Data protection Impressum

Financing

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

Colb Asset SA, a Geneva-based fintech company specializing in real-world asset tokenization, has secured CHF 6 million in an oversubscribed seed extension round. The funding aims to broaden access to traditionally exclusive investment opportunities through blockchain technology.

Geneva-based Colb raises CHF 6 million to tokenize pre-IPO investments on blockchain

13 May 2025

DemoSquare has successfully raised CHF 1.2 million in pre-seed funding to fuel its expansion into European markets, aiming to enhance its AI-based platform for monitoring political and regulatory activities.

DemoSquare launches EU platform in Brussels to expand AI-based policy monitoring

13 May 2025

The Lausanne Region Trophy at the 23rd Prix Entreprendre Lausanne Région (PERL) ceremony has been awarded to Carewell, a Pully-based start-up optimizing healthcare staffing through a digital platform that merges technological and social innovation.

Carewell wins 2025 PERL Award for innovation in healthcare staffing

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea raises USD 9 million to scale green hydrogen production technologies

6 May 2025

Four innovative Geneva-based start-ups have received funding from the FONGIT Innovation Fund (FIF), highlighting the canton’s continued support for impactful technologies in life sciences and sustainable mobility.

Geneva-based start-ups awarded FIF funding to accelerate innovation in health and mobility

5 May 2025

Neuchâtel health tech company Aktiia has announced its rebranding to Hilo, alongside the closing of a USD 42 million Series B funding round. The new capital will support the international growth of its cuffless blood pressure monitoring platform and further product development.

Aktiia becomes Hilo and raises USD 42 million to accelerate global expansion

5 May 2025

1 2 3 4 5 6 7 … 33